<?xml version="1.0" encoding="UTF-8"?>
<akomaNtoso xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">
  <act name="PBH">
    <meta>
      <identification source="#ny-legislature">
        <FRBRWork>
          <FRBRthis value="/akn/us-ny/act/pbh/section-505"/>
          <FRBRuri value="/akn/us-ny/act/pbh/section-505"/>
          <FRBRdate date="2014-09-22" name="enacted"/>
          <FRBRauthor href="#ny-legislature"/>
          <FRBRcountry value="us-ny"/>
          <FRBRnumber value="505"/>
          <FRBRname value="PBH"/>
        </FRBRWork>
        <FRBRExpression>
          <FRBRthis value="/akn/us-ny/act/pbh/section-505/eng@2025-12-31"/>
          <FRBRuri value="/akn/us-ny/act/pbh/section-505/eng@2025-12-31"/>
          <FRBRdate date="2025-12-31" name="publication"/>
          <FRBRauthor href="#arch"/>
          <FRBRlanguage language="eng"/>
        </FRBRExpression>
        <FRBRManifestation>
          <FRBRthis value="/akn/us-ny/act/pbh/section-505/eng@2025-12-31/main.xml"/>
          <FRBRuri value="/akn/us-ny/act/pbh/section-505/eng@2025-12-31/main.xml"/>
          <FRBRdate date="2025-12-31" name="generation"/>
          <FRBRauthor href="#arch"/>
        </FRBRManifestation>
      </identification>
      <references source="#arch">
        <TLCOrganization eId="arch" href="https://cosilico.ai" showAs="Cosilico Arch"/>
        <TLCOrganization eId="ny-legislature" href="https://legislation.nysenate.gov" showAs="New York State Legislature"/>
      </references>
    </meta>
    <body>
      <section eId="sec_505">
        <num>505</num>
        <heading>Animal irritancy tests prohibited</heading>
        <subsection eId="sec_505__subsec_a">
          <num>(a)</num>
          <content>
            <p>"Animal" means a vertebrate nonhuman animal.\n</p>
          </content>
        </subsection>
        <subsection eId="sec_505__subsec_b">
          <num>(b)</num>
          <content>
            <p>"Contract testing facility" means any individual, partnership,\ncorporation, association, or other legal relationship that tests\nchemicals, ingredients, product formulations, or products in this state.\n</p>
          </content>
        </subsection>
        <subsection eId="sec_505__subsec_c">
          <num>(c)</num>
          <content>
            <p>"ICCVAM" means the Inter-Agency Coordinating Committee for the\nValidation of Alternative Methods, a federal committee comprised of\nrepresentatives from fourteen federal regulatory or research agencies,\nincluding the Food and Drug Administration, Environmental Protection\nAgency, and Consumer Products Safety Commission, that reviews the\nvalidity of alternative test methods. The committee is the federal\nmechanism for recommending appropriate, valid test methods to relevant\nfederal agencies.\n</p>
          </content>
        </subsection>
        <subsection eId="sec_505__subsec_d">
          <num>(d)</num>
          <content>
            <p>"Manufacturer" means any individual, partnership, corporation,\nassociation, or other legal relationship that produces chemicals,\ningredients, product formulations, or products in this state.\n</p>
          </content>
        </subsection>
        <subsection eId="sec_505__subsec_e">
          <num>(e)</num>
          <content>
            <p>"Medical research" means research related to the causes,\ndiagnosis, treatment, control or prevention of physical or mental\ndiseases and impairments of humans and animals, or related to the\ndevelopment of biomedical products, devices or drugs as defined in\nSection 321</p>
          </content>
        </subsection>
        <subsection eId="sec_505__subsec_g">
          <num>(g)</num>
          <paragraph eId="sec_505__subsec_g__subsec_1">
            <num>(1)</num>
            <content>
              <p>of Title 21 of the United States Code. Medical\nresearch does not include the testing of an ingredient that was formerly\nused in a drug, tested for the drug use with traditional animal methods\nto characterize the ingredient and to substantiate its safety for human\nuse, and is now proposed for use in a product other than a biomedical\nproduct, medical device or drug.\n</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_505__subsec_f">
          <num>(f)</num>
          <content>
            <p>"Person" means any individual, partnership, corporation,\nassociation or other legal entity.\n</p>
          </content>
        </subsection>
        <subsection eId="sec_505__subsec_g">
          <num>(g)</num>
          <content>
            <p>"Traditional animal test method" means a process or procedure\nusing animals to obtain information on the characteristics of a chemical\nor agent. Toxicological test methods generate information regarding the\nability of a chemical or agent to product a specific biological effect\nunder specified conditions.\n</p>
          </content>
        </subsection>
        <subsection eId="sec_505__subsec_h">
          <num>(h)</num>
          <content>
            <p>"Validated alternative test method" means a test method that does\nnot use animals, or in some cases reduces or refines the current use of\nanimals for which the reliability and relevance for a specific purpose\nhas been established in validation studies as specified in the ICCVAM\nreport provided to the relevant federal agencies.\n</p>
          </content>
        </subsection>
      </section>
    </body>
  </act>
</akomaNtoso>